Authors
Loading...
AI may accelerate cardiovascular drug candidate screening; leaves open prospective validation before clinical adoption.
Key points are not available for this paper at this time.
Triggle et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: